TWINSTRAND BIOSCIENCES INC.

In News

U.S. court orders Guardant to pay $245 million in DNA sequencing patent dispute - Reuters

Reuters - Aug 24, 2026

TwinStrand, UW awarded $245 million in patent infringement suit - The Business Journals

The Business Journals - Aug 25, 2026

A court orders Guardant Health to pay $245.2M and 6% royalties through 2033 - Stock Titan

Stock Titan - Aug 24, 2026

Guardant Can Try Again To Nix Patent Tied To $83M Verdict - Law360

Law360 - Jan 23, 2026

TwinStrand Biosciences and Exact Sciences Announce Exclusive License Agreement for Duplex Sequencing Technology - PR Newswire

PR Newswire - Jul 31, 2024

Guardant Health hit with $83M verdict in TwinStrand DNA sequencing patent lawsuit - Fierce Biotech

Fierce Biotech - Nov 15, 2023

Guardant Fails to Undo $83 Million DNA-Tech Patent Verdict (1) - Bloomberg Law News

Bloomberg Law News - Jun 17, 2026

US Court to pharma giant Guardant Health: You willfully infringed patents for cancer-testing; asked to pa - The Times of India

The Times of India - Aug 26, 2026

Duplex Sequencing Technology Detects Early Carcinogen-Caused Mutagenesis - The American Journal of Managed Care

The American Journal of Managed Care - Dec 18, 2020

Guardant Health owes $83.4 mln in DNA sequencing patent case, US jury says - Reuters

Reuters - Nov 15, 2023

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment